Who owns SAB Biotherapeutics Inc?
- CUSIP Number: 78397t103
Tip: Access positions for across all investors
Analyze quarterly positions in SAB Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of SAB Biotherapeutics stock
Who bought or sold SAB Biotherapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Kestra Advisory Services | 88k | $61k | 319% | Dec 2023 |
|
| Baird Financial | 10k | $6.9k | 0% | Dec 2023 |
|
Who sold out of SAB Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BVF | Dec 2023 | 9.2M | $6.3M |
| Sessa Capital IM | Dec 2023 | 4.6M | $3.2M |
| Vanguard Group | Dec 2023 | 996k | $685k |
| First PREMIER Bank | Dec 2023 | 808k | $555k |
| Pathstone Holdings | Dec 2023 | 507k | $348k |
| Geode Capital Management | Sep 2023 | 356k | $225k |
| First Manhattan | Sep 2023 | 278k | $175k |
| Institutional & Family Asset Management | Dec 2023 | 192k | $132k |
| Mariner Wealth Advisors | Dec 2023 | 69k | $47k |
| BlackRock | Sep 2023 | 53k | $33k |
| Peapack Gladstone Financial Corp | Sep 2023 | 52k | $33k |
| Silver Oak Securities | Dec 2023 | 52k | $36k |
| Creative Planning | Dec 2023 | 48k | $33k |
| Advisor Group Holdings | Dec 2023 | 46k | $32k |
| Northern Trust | Sep 2023 | 45k | $28k |
| Citadel Advisors | Dec 2023 | 17k | $12k |
| Charles Schwab Investment Management | Dec 2023 | 16k | $11k |
| Morgan Stanley | Sep 2023 | 15k | $9.7k |
| Tower Research Capital | Sep 2023 | 15k | $9.4k |
| Nadler Financial | Dec 2023 | 14k | $9.5k |
| Commonwealth Equity Services | Dec 2023 | 13k | $9.0k |
| 1st Source Bank | Dec 2023 | 10k | $6.9k |